Tirol Clinic, Medical University of Innsbruck
Innsbruck, Austria
Tirol Kliniken, Medical University of Innsbruck, has joined IASIOS as an Enrolled Centre, marking the start of its accreditation pathway and a strong commitment to high standards in interventional oncology.
By entering the IASIOS programme, the facility aligns with internationally recognised principles of quality assurance, patient safety, and multidisciplinary cancer care. IASIOS accreditation provides a structured framework for evaluation, peer review, and continuous quality improvement, supporting the delivery of safe, consistent, high-quality, image-guided treatments.
We are pleased to welcome the team and look forward to supporting their progress towards IASIOS accreditation.
ASST Niguarda Great Metropolitan Hospital
Italy, Milan
ASST Niguarda Great Metropolitan Hospital is now part of IASIOS as an Enrolled Centre, marking the beginning of its accreditation pathway and reinforcing its commitment to high standards in interventional oncology.
By joining IASIOS, the facility aligns with internationally recognised principles of quality assurance, patient safety, and multidisciplinary cancer care. IASIOS accreditation provides a structured framework for evaluation, peer review, and continuous quality improvement, supporting the delivery of safe, consistent, high-quality, image-guided treatments.
We are pleased to welcome the team and look forward to accompanying them on their path towards IASIOS accreditation.
Geneva University Hospitals
Geneva, Switzerland
Our congratulations to Geneva University Hospitals on achieving IASIOS Accredited Centre status. This recognition confirms that the interventional oncology service delivers consistent, high-quality care aligned with internationally recognised standards for quality assurance, patient safety, and multidisciplinary cancer care.
IASIOS accreditation is based on the CIRSE Standards of Quality Assurance in Interventional Oncology, providing a structured framework for clinical excellence, governance, and continuous quality improvement across the patient pathway.
We recognise Dr Alexis Ricoeur and the entire interventional radiology team for their commitment to advancing high-quality interventional oncology services and setting a strong example within the international IO community.
Mater Misericordiae University Hospital
Dublin, Ireland
Mater Misericordiae University Hospital has joined IASIOS as an Enrolled Centre, demonstrating its commitment to patient safety and high-quality clinical practice. As interventional oncology continues to be recognised as a core pillar of multidisciplinary oncology and integrated into comprehensive cancer care strategies, this step reflects a clear focus on structured, standardised care.
IASIOS provides a framework for structured evaluation, peer review, and continuous quality improvement, supporting institutions in delivering safe, consistent, high-quality interventional oncology services.
We look forward to supporting the team as they progress along the IASIOS accreditation pathway.
Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital
Ankara, Turkey
Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital has joined IASIOS as an Enrolled Centre, marking the start of its accreditation pathway and a commitment to internationally recognised standards in interventional oncology.
This step reflects a focus on quality assurance, patient safety, and multidisciplinary cancer care. IASIOS accreditation provides a structured framework for evaluation, peer review, and continuous quality improvement, supporting the delivery of safe, consistent, high-quality, image-guided treatments.
We look forward to supporting the team as they progress towards accreditation.
The Mediterranean Hospital of Cyprus
Limassol, Cyprus
The Mediterranean Hospital of Cyprus has joined IASIOS as an Enrolled Centre, becoming the first in Cyprus. This step reflects the team’s commitment to aligning with internationally recognised standards in interventional oncology, with a focus on quality assurance, patient safety, and structured, multidisciplinary cancer care.
IASIOS enrolment marks the beginning of a clear pathway towards accreditation, supporting centres in strengthening clinical practice and delivering consistent, high-quality, image-guided treatments.
We look forward to supporting the team as they progress towards accreditation.
The National Cancer Institute of Milan
Milan, Italy
We congratulate the National Cancer Institute of Milan (Fondazione IRCCS Istituto Nazionale dei Tumori di Milano) on achieving IASIOS Accredited Centre status. The facility meets the core criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology, supported by more than 40 national and international societies. These standards provide a structured framework for clinical excellence, patient safety, and operational quality across the entire patient pathway.
This accreditation highlights the team’s commitment to quality assurance in interventional oncology and to delivering safe, standardised, and high-quality cancer care. We recognise Dr Alfonso Marchianò, Dr Tommaso Cascella, and the entire interventional radiology team for reaching this milestone.
IRCCS Fondazione Istituto Nazionale Tumori
Milan, Italy
We are pleased to announce that IRCCS Fondazione Istituto Nazionale Tumori in Italy has been awarded IASIOS Accredited Centre status. This recognition confirms that its interventional oncology service meets internationally established standards for quality assurance, patient safety, and multidisciplinary cancer care.
IASIOS accreditation reflects a strong institutional commitment to structured clinical processes, evidence-based practice, and the ongoing advancement of interventional oncology. It also underscores the important role of image-guided, minimally invasive therapies in delivering modern, high-quality cancer care.
Congratulations to Dr. Tommaso Cascella and team on this achievement as it marks a significant contribution to the continued development of interventional oncology standards at both national and international levels.
CHU de Nice
Nice, France
We are pleased to congratulate CHU de Nice on achieving IASIOS Accredited Centre status. This milestone reflects the centre’s strong commitment to patient safety and clinical quality in interventional oncology.
As interventional oncology is increasingly recognised as a core pillar of multidisciplinary cancer care, dedication to standardised practice and structured evaluation is truly commendable.
Congratulations to Prof. Chevallier and the entire interventional radiology team on this achievement. Your dedication to advancing high-quality patient care is truly appreciated.
Institut Bergonié
Bordeaux, France
We are proud to announce that Institut Bergonié in France has been recognized as an IASIOS Centre of Excellence, joining a growing network of leading institutions worldwide that have achieved this prestigious distinction.
The Centre of Excellence designation represents the highest level of recognition within IASIOS, confirming that Institut Bergonié fulfils both the core and extended criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology.
This achievement reflects a fully integrated and meticulously structured interventional oncology pathway, ensuring that every patient receives consistent, safe, and high-quality care. From staff expertise and multidisciplinary collaboration to advanced infrastructure, precise treatment delivery, and rigorous radiation safety standards, excellence is demonstrated across every aspect of its IO service.
We commend the dedication and leadership of Dr. Palussière, Dr. Buy, Ms. Gouze, and Ms. Enfedaque, whose commitment to quality and patient-centred care has been instrumental in reaching this milestone.
Their accomplishment represents a significant contribution to advancing standards in interventional oncology and serves as an inspiration to the global IO community.
Dr. Jean Palussière
IASIOS Committee Chairperson
(Bordeaux, France)